Verubecestat (MK-8931)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Verubecestat (MK-8931), covering 2015-10-23 to 2015-10-23. Get the full timeline:
Most recent: Clinical Trial Update: A Study of the Safety, Tolerability, and Pharmacodynamics of MK-8931 in Participants With Alzheimer's Disease (MK-8931-010 AM1 [P07820 AM1]) [Phase 1]